Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease

Journal article

Open access

Peer reviewed

Alimentary pharmacology & therapeutics, Vol.47(4), pp.535-536

02/2018

Handle:

https://hdl.handle.net/10523/36983

Abstract

Linked Content This article is linked to Tadbiri et al. To view this article visit https://doi.org/10.1111/apt.14419.

url

https://doi.org/10.1111/apt.14465View

Published (Version of record) Open

2 Record Views

Record Identifier: 9926529292901891
Title: Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease
Creators: M. L. Barclay
L. K. Stamp
Publication Details: Alimentary pharmacology & therapeutics, Vol.47(4), pp.535-536
Academic Unit: Medicine (UOC)
Date published ; e-published: 02/2018
Language: English
Resource Type ; Subtype: Journal article